Osaic Holdings
ONCY

Osaic Holdings’s Oncolytics Biotech ONCY Stock Holding History

Osaic Holdings’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.97K Buy
8,200
+2,637
+47% +$2.62K ﹤0.01% 6502
2025
Q4 		$4.84K Buy
5,563
+5,500
+8,730% +$5.94K ﹤0.01% 6721
2025
Q3 		$88 Sell
63
-6,741
-99% -$7.55K ﹤0.01% 7756
2025
Q2 		$5.19K Buy
6,804
+3,496
+106% +$1.85K ﹤0.01% 6523
2025
Q1 		$1.82K Buy
3,308
+1,263
+62% +$924 ﹤0.01% 6633
2024
Q4 		$1.88K Sell
2,045
-6,452
-76% -$6.71K ﹤0.01% 6632
2024
Q3 		$7.42K Hold
8,497
– – ﹤0.01% 5999
2024
Q2 		$8.41K Sell
8,497
-4,842
-36% -$5.27K ﹤0.01% 5890
2024
Q1 		$14.2K Buy
13,339
+4,127
+45% +$4.61K ﹤0.01% 5551
2023
Q4 		$12.4K Sell
9,212
-500
-5% -$782 ﹤0.01% 5729
2023
Q3 		$21.2K Sell
9,712
-2,674
-22% -$6.53K ﹤0.01% 5524
2023
Q2 		$32.8K Sell
12,386
-225,696
-95% -$375K ﹤0.01% 5231
2023
Q1 		$286K Buy
238,082
+229,750
+2,757% +$361K ﹤0.01% 3588
2022
Q4 		$13K Buy
8,332
+842
+11% +$1.28K ﹤0.01% 5814
2022
Q3 		$10K Hold
7,490
– – ﹤0.01% 6018
2022
Q2 		$8K Sell
7,490
-527
-7% -$641 ﹤0.01% 6244
2022
Q1 		$11K Buy
8,017
+5,055
+171% +$8.48K ﹤0.01% 6083
2021
Q4 		$4K Hold
2,962
– – ﹤0.01% 6763
2021
Q3 		$6K Sell
2,962
-1,500
-34% -$3.4K ﹤0.01% 6453
2021
Q2 		$12K Buy
4,462
+500
+13% +$1.53K ﹤0.01% 5958
2021
Q1 		$16K Buy
3,962
+1,000
+34% +$2.98K ﹤0.01% 5621
2020
Q4 		$7K Sell
2,962
-67
-2% -$161 ﹤0.01% 5664
2020
Q3 		$6K Hold
3,029
– – ﹤0.01% 5514
2020
Q2 		$6K Sell
3,029
-7,020
-70% -$13.2K ﹤0.01% 5410
2020
Q1 		$13K Buy
+10,049
New +$25.1K ﹤0.01% 4876

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Osaic Holdings's ONCY Position: Q1 2026 in Review

Osaic Holdings increased its Oncolytics Biotech (ONCY) stake by 47% in Q1 2026, buying an estimated $2.62K and bringing the position to 8,200 shares worth $6.97K. The position accounts for ﹤0.01% of the portfolio, ranked #6502.

Osaic Holdings first reported a position in ONCY in Q1 2020 and has held it in 25 quarters since. The position peaked at $286K in Q1 2023. 59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.

  • Osaic Holdings held 8,200 shares of Oncolytics Biotech worth $6.97K as of Q1 2026.
  • Osaic Holdings bought 2,637 Oncolytics Biotech shares in Q1 2026, an estimated $2.62K.
  • Oncolytics Biotech made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6502 holding.
  • Osaic Holdings first reported a position in Oncolytics Biotech in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Oncolytics Biotech position peaked at $286K in Q1 2023.
  • 59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.